Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
Rapid Diagnostics Play Prominent Role in Federal Plan to Combat Antibiotic Resistance
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies The White House recently unveiled a comprehensive, federal plan to combat the growing threat of antibiotic-resistant bacteria. Diagnostics play a prominent role in the national action plan. The...
CAP, AMP, ASCP and ASCO Welcome Public Comment on Colorectal Cancer Guidelines
By Kelly A. Briganti, Editorial Director, G2 Intelligence Clinical practice guidelines addressing colorectal cancer testing were released for public comment, through the joint efforts of the American Society for Clinical Pathology (ASCP), the College of American...
Rosetta Genomics Obtains Patent for Kidney Cancer Test
By Ron Shinkman, Editor, Laboratory Industry Report New Jersey-based Rosetta Genomics has received a patent for its kidney cancer assay, the company announced this week. Rosetta received a patent for its gene expression test, which can identify four types of kidney...
Rutgers Cancer Institute Teams with Meridian Health for ‘Precision Medicine’ Clinical Trial
By Stephanie Murg, Managing Director, G2 Intelligence Rutgers Cancer Institute of New Jersey (New Brunswick, N.J.) is taking a personalized approach to clinical trials. The National Cancer Institute-designated Comprehensive Cancer Center is partnering with the...